insights_auto
Why is PLX down 2.29%?
Dive Deeperchevron_right
PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.56
arrow_downward
-2.29%(-0.060) 1D
$2.56
arrow_downward
-0.15% (-0.0039)bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.63
High
$2.66
Low
$2.54
Mkt. cap
206.26M
Avg. vol.
877.10K
Volume
914.63K
P/E ratio
11.32
52-wk high
$3.19
52-wk low
$1.65
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
Open
$2.63
High
$2.66
Low
$2.54
Mkt. cap
206.26M
Avg. vol.
877.10K
Volume
914.63K
P/E ratio
11.32
52-wk high
$3.19
52-wk low
$1.65
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
BBN Times
·
15 minutes ago
S&P 500 Rises to 7,690.73 as Tech and AI Stocks Rebound From Worst Week Since June Amid US-Iran Negotiations
TradingView
·
1 hour ago
The Dow Jones Index Closes 0.07% Lower
ChartMill
·
55 minutes ago
S&P 500 After-Hours Losers on Oct. 19: DGX, COP, STLD, WRB
Investor's Business Daily
·
31 minutes ago
Dow Jones Futures: AMD, Nvidia Lead AI Trade Higher; Meta, Netflix, SpaceX, Tesla Earnings On Deck
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com